Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GMEG | Xetra | EUR | Delayed | |
GMEG | TradeGate | EUR | Delayed | |
GMEG | Frankfurt | EUR | Delayed |
For the three months ended 31 March 2022, Geratherm Medical AG revenues decreased 4% to EUR6.4M. Net income increased 3% to EUR436K. Revenues reflect Healthcare Diagnostics segment decrease of 11% to EUR4.1M, Respiratory segment decrease of 11% to EUR1.3M, Europe segment decrease of 12% to EUR3.3M, Middle East segment decrease of 45% to EUR386K, Germany segment decrease of 8% to EUR1.3M.
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 6.41 | 5.8 | 5.74 | 5.74 |
Gross Profit | 4.36 | 3.87 | 4.05 | 4.02 |
Operating Income | 0.72 | -1.25 | 0.76 | 0.31 |
Net Income | 0.44 | -0.93 | 0.43 | 0.2 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 35.39 | 34.56 | 35.22 | 34.83 |
Total Liabilities | 16.8 | 16.04 | 15.47 | 15.65 |
Total Equity | 18.59 | 18.52 | 19.75 | 19.18 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | 0.16 | 0.92 | 0.74 | 0.22 |
Cash From Investing Activities | -0.75 | 0 | 0.2 | 0.45 |
Cash From Financing Activities | -0.11 | -3.52 | -3.22 | -2.76 |
Net Change in Cash | -0.69 | -2.59 | -2.23 | -2.06 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review